Summary
The product Nandrolone-D 300, manufactured by Pharmaqo, underwent independent testing to verify its authenticity and potency. The sample, with an unknown batch number, was submitted by the Manufacturer Pharmaqo Labs mrp@vitamins.to and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Nandrolone Decanoate, with a concentration of 308.87 mg/ml, slightly exceeding the labeled claim of 300 mg/ml by 2.96%.
The testing process began on 1 February 2024, with the sample received and analyzed on the same day. While the results confirm accurate dosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Nandrolone-D 300
- Active Ingredient: Nandrolone Decanoate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #38110
- Testing Ordered: 1 February 2024
- Sample Received: 1 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 300 mg/ml (as stated on the label)
- Measured Concentration: 308.87 mg/ml
- Accuracy: 102.96% (2.96% above the label claim)
- Variance: 2.96
Verification Details
- Verification URL: https://janoshik.com/tests/38110_21JFN3CYRA79
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by theManufacturer Pharmaqo Labs mrp@vitamins.to. Manufacturer-submitted samples may not fully represent the consistency of products available in the broader market. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Nandrolone-D 300 is slightly overdosed, with a measured concentration of 308.87 mg/ml. This result reflects strong quality control for this sample but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
